Other OTC - Delayed Quote • USD
Atreca, Inc. (BCEL)
At close: April 26 at 3:34 PM EDT
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Expense
78,377.0000
98,295.0000
110,303.0000
88,879.0000
Operating Income
-78,377.0000
-98,295.0000
-110,303.0000
-88,879.0000
Net Non Operating Interest Income Expense
1,663.0000
817.0000
204.0000
1,214.0000
Other Income Expense
-21,042.0000
321.0000
774.0000
1,331.0000
Pretax Income
-97,756.0000
-97,157.0000
-109,325.0000
-86,334.0000
Tax Provision
--
--
1.0000
1.0000
Net Income Common Stockholders
-97,756.0000
-97,157.0000
-109,326.0000
-86,335.0000
Diluted NI Available to Com Stockholders
-97,756.0000
-97,157.0000
-109,326.0000
-86,335.0000
Basic EPS
-2.50
-2.52
-2.95
-2.70
Diluted EPS
-2.50
-2.52
-2.95
-2.70
Basic Average Shares
39,169.6820
38,593.8940
37,038.1950
31,924.4730
Diluted Average Shares
39,169.6820
38,593.8940
37,038.1950
31,924.4730
Total Expenses
78,377.0000
98,295.0000
110,303.0000
88,879.0000
Net Income from Continuing & Discontinued Operation
-97,756.0000
-97,157.0000
-109,326.0000
-86,335.0000
Normalized Income
-76,451.0000
-96,708.0000
-109,249.0000
-86,313.0000
Interest Income
1,663.0000
817.0000
207.0000
1,218.0000
Interest Expense
--
--
3.0000
4.0000
Net Interest Income
1,663.0000
817.0000
204.0000
1,214.0000
EBIT
-77,239.0000
-97,157.0000
-109,322.0000
-86,330.0000
EBITDA
-70,597.0000
-90,076.0000
-104,772.0000
-83,953.0000
Reconciled Depreciation
6,642.0000
7,081.0000
4,550.0000
2,377.0000
Net Income from Continuing Operation Net Minority Interest
-97,756.0000
-97,157.0000
-109,326.0000
-86,335.0000
Total Unusual Items Excluding Goodwill
-21,305.0000
-449.0000
-77.0000
-22.0000
Total Unusual Items
-21,305.0000
-449.0000
-77.0000
-22.0000
Normalized EBITDA
-49,292.0000
-89,627.0000
-104,695.0000
-83,931.0000
12/31/2020 - 6/20/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BDTX Black Diamond Therapeutics, Inc.
5.89
+15.26%
GOSS Gossamer Bio, Inc.
0.6680
-0.30%
STOK Stoke Therapeutics, Inc.
12.41
+6.16%
BLPH Bellerophon Therapeutics, Inc.
0.0554
+0.73%
BTTX Better Therapeutics, Inc.
0.0100
+11.11%
ALEC Alector, Inc.
5.25
+9.15%
PASG Passage Bio, Inc.
1.3200
+8.20%
CABA Cabaletta Bio, Inc.
11.01
-9.61%
AKRO Akero Therapeutics, Inc.
19.74
+4.28%
TYRA Tyra Biosciences, Inc.
15.67
+3.71%